Phosphorus--nitrogen compounds XXIII: Oncolytic phosphorylated imines

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Pharmacology

Background:

• Development of novel anticancer agents is crucial for improving cancer therapy.
• Phosphorus-containing heterocyclic compounds and their derivatives are explored for biological activities.
• Understanding structure-activity relationships is key to designing effective antitumor drugs.

Purpose of the Study:

• To synthesize a novel series of amidine, iminopiperidine, iso(thio)urea, guanidine derivatives, and triazaphosphorines.
• To evaluate the synthesized compounds for their reactivity with L-cysteine.
• To assess the antitumor activity of these compounds against sarcoma 180 and P-388 murine tumor models.

Main Methods:

• Chemical synthesis of 15 acyclic derivatives and 6 triazaphosphorines.
• In vitro testing of compound reactivity with L-cysteine.
• In vivo evaluation of antitumor efficacy using sarcoma 180 and P-388 murine tumor systems.

Main Results:

• Three acyclic phosphorylated imines and one triazaphosphorine derivative demonstrated significant antitumor activity.
• The P(O)N=C functional group was identified as a potential oncolytic moiety.
• A correlation was observed between higher reactivity with L-cysteine and enhanced antitumor activity.

Conclusions:

• The synthesized compounds, particularly those containing the P(O)N=C group, show promise as anticancer agents.
• Reactivity with L-cysteine can serve as an indicator for potential antitumor efficacy.
• Further investigation into these phosphorus-containing compounds could lead to new therapeutic strategies.